Accendra Health
ACH
Accendra Health (ACH) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| UBS | Maintained | Neutral | $1.50 from $4.50 | Aug 13, 2026 |
| Citigroup | Downgraded | Buy → Neutral | $1.50 from $4.50 | Aug 11, 2026 |
| Citigroup | Maintained | Buy | $4.50 from $5.00 | Jul 24, 2026 |
| Baird | Maintained | Outperform | $6.00 from $5.00 | May 12, 2026 |
| Citigroup | Maintained | Buy | $5.00 from $3.25 | May 12, 2026 |
| UBS | Maintained | Neutral | $4.50 from $3.00 | May 12, 2026 |
| Leerink Partners | Maintained | Market Perform | $2.75 from $3.00 | Feb 20, 2026 |
| Citigroup | Maintained | Buy | $4.00 from $7.00 | Jan 9, 2026 |
| UBS | Downgraded | Buy → Neutral | $4.00 from $7.00 | Nov 3, 2025 |
| JP Morgan | Maintained | Underweight | $6.00 from $7.00 | Aug 27, 2025 |
| UBS | Maintained | Buy | $7.00 from $13.00 | Aug 13, 2025 |
| B of A Securities | Maintained | Underperform | $4.75 from $7.50 | Aug 12, 2025 |
| Citigroup | Maintained | Buy | $7.00 from $11.00 | Aug 12, 2025 |
| Baird | Maintained | Outperform | $7.00 from $10.00 | Aug 12, 2025 |
| Baird | Maintained | Neutral | $10.00 from $9.00 | Jun 6, 2025 |
| Citigroup | Maintained | Buy | $11.00 from $13.00 | Apr 17, 2025 |
| JP Morgan | Maintained | Underweight | $10.00 from $14.00 | Mar 10, 2025 |
| Baird | Maintained | Neutral | $11.00 from $10.00 | Mar 3, 2025 |
| Baird | Maintained | Neutral | $10.00 from $14.00 | Feb 25, 2025 |
| UBS | Maintained | Buy | $13.00 from $25.00 | Feb 13, 2025 |
Frequently asked questions
What is the latest analyst rating on ACH?
On Aug 13, 2026, UBS maintained Accendra Health at Neutral with a price target of $1.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.